On Thursday, Israeli health officials announced that booster shots of the Pfizer-BioNTech vaccine will be available. In briefings to U.S. experts addressing a booster shot of Moderna’s vaccine, the COVID-19 vaccine enhanced severe illness protection in patients of age 40 and up, Reuters reports.
The findings were revealed at a conference of independent advisors to the U.S. Food and Drug Administration, who are scheduled to vote later Thursday on whether a booster shot of the Moderna vaccine is required at least six months after the first two-shot vaccination. The FDA usually heeds the recommendations of its specialists, but it is not obligated to do so.
Moderna is requesting permission for a booster shot with 50 micrograms of vaccine, which is half the power of its usual dosage but still more than the Pfizer-BioNTech shot, which has 30 micrograms of the vaccine.
According to panel member, Dr. Ofer Levy, it’s essential to note that the US and Israel have different demographics and that the vaccination Israel used is dissimilar, but that the Israel findings are significant because both employ comparable mRNA technology.
The panel will decide whether the Moderna booster shot should be administered six months following the second shot to persons aged 65 and above, individuals at high risk of severe symptoms of coronavirus, and adults aged 18 to 64 who are at risk of COVID-19 infections because of their occupations.
If the FDA approves the Moderna booster shot, the Centers for Disease Control and Prevention will issue precise directions about who should receive the injections.
According to Dr. Sharon Alroy-Preis, head of public health services at Israel’s Ministry of Health, the booster immunization campaign, which now encompasses at least half of the population across all age categories, is beginning to lower outbreaks even among Israel’s unvaccinated communities.
Israel has been rigorously tracking vaccinations in its nation, revealing that providing a booster shot resulted in better protection against proven illness in those aged 16 and above.